Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionTwo Sigma Advisers, Lp
Latest Disclosed Ownership604,540 shares
Latest Disclosed Value $ 466,626,290
Two Sigma Advisers, Lp ownership in REGN / Regeneron Pharmaceuticals, Inc.

On February 17, 2026 - Two Sigma Advisers, Lp filed a 13F-HR form disclosing ownership of 604,540 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $466,626,290 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 926,200 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -34.73% during the quarter.

Two Sigma Advisers, Lp has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 604,540 -321,660 -34.73 466,626 -10.40 0.9072
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 926,200 -12,300 -1.31 520,774 5.70 1.0422
2025-08-14 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 938,500 384,700 69.47 492,712 40.28 1.0096
2025-05-15 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 553,800 553,800 351,237 0.7908
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -900 -100.00 0 -100.00
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 900 -100 -10.00 946 -9.99 0.0022
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,000 1,000 1,051 0.0023
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -12,900 -100.00 0 -100.00
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 12,900 -230,000 -94.69 11,330 -94.33 0.0265
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 242,900 -56,400 -18.84 199,897 -7.05 0.5120
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 299,300 89,500 42.66 215,059 24.75 0.5478
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 209,800 161,300 332.58 172,386 392.64 0.4446
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 48,500 -67,400 -58.15 34,992 -56.17 0.0977
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 115,900 -163,100 -58.46 79,840 -51.59 0.2311
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 279,000 -210,200 -42.97 164,925 -51.73 0.4679
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 489,200 100,700 25.92 341,667 39.26 0.9082
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 388,500 388,500 245,346 0.6145
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -52,799 -100.00 0 -100.00
2020-11-16 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 52,799 -69,100 -56.69 29,556 -61.12 0.0844
2020-09-15 2020-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 121,899 72,299 145.76 76,022 213.89 0.2234
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 121,899 72,299 76,022 219,678.3320
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 49,600 10,498 26.85 24,219 64.96 0.0927
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 39,102 -244,199 -86.20 14,682 -81.32 0.0341
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 283,301 42,300 17.55 78,588 4.18 0.1924
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 241,001 -50,600 -17.35 75,433 -37.00 0.1877
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 291,601 -279,400 -48.93 119,737 -43.86 0.3019
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 571,001 -45,800 -7.43 213,269 -14.42 0.5825
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 616,801 -122,300 -16.55 249,212 -2.26 0.6082
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 739,101 38,800 5.54 254,982 5.73 0.6859
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 700,301 319,263 83.79 241,156 68.34 0.6539
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 381,038 381,038 143,255 0.3862
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -2,588 -100.00 0 -100.00
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,588 -185,513 -98.62 1,271 -98.26 0.0042
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 188,101 -19,679 -9.47 72,891 -4.44 0.2390
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 207,780 -57,400 -21.65 76,274 -28.45 0.2917
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 265,180 -122,000 -31.51 106,608 -21.16 0.4541
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 387,180 -15,300 -3.80 135,215 -6.79 0.6869
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 402,480 148,813 58.66 145,070 5.35 0.8118
2016-02-16 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 253,667 25,170 11.02 137,708 29.01 0.8206
2015-11-16 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 228,497 228,497 0.00 106,743 0.6731
2016-02-09 2015-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 0 -480 -100.00 0 -100.00
2016-02-09 2015-03-31 13F/A-2 REGENERON PHARMACEUTICALS COM 75886F107 480 480 -94.94 217 -93.65 0.0376
2015-02-17 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -9,480 -100.00 0 -100.00
2016-02-09 2014-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 9,480 9,480 0.00 3,418 0.0269
2014-11-14 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 9,480 3,418
2014-08-14 2014-06-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 0 -6,280 -100.00 0 -100.00
2014-05-15 2014-03-31 13F Regeneron Pharmaceuticals Common Stock 75886F107 6,280 -2,500 -28.47 1,885 -22.01 0.0171
2014-02-14 2013-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,780 -97,400 -91.73 2,417 -92.72 0.0233
2013-11-14 2013-09-30 13F Regeneron Pharmaceuticals Common Stock 75886F107 106,180 -82,500 -43.72 33,220 -21.71 0.3959
2013-08-14 2013-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 188,680 188,680 42,430 0.6065
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-02-14 2013-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F REGENERON PHARMACEUTICALS COM Call 1,000 313 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2016-02-09 2014-09-30 13F/A REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-09 2014-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 2,000 0.00 565 -9.74 n/a n/a n/a
2014-02-14 2013-12-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F REGENERON PHARMACEUTICALS COM Put 2,000 626 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.